| 摘要 |
<p>The invention relates to extended dosing regimens dosing every second day to once a week for selective estrogen receptor modulator bazedoxifene (1-[4-(2- azepan-1-yl-ethoxy)-benzyl]-2-(4-hydroxy-phenyl)-3-methyl-lH-indol-5-ol) useful for in the preparation of a medicament for treating or inhibiting osteoporosis, bone loss, hypercholesteremia, hyperlipidemia, cardiovascular diseases, dementia, neurodegenerative disorders and Alzheimer's disease.</p> |
